Invitrogen™ Mouse CD80 ELISA Kit

Ref.: BL-RE-093374Manufacturer ref.: EM16RBX5 5 x 96 tests
€2,950.00 excl. VAT

Mouse CD80 quantitates mouse CD80 in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant mouse CD80.

Accession number
Antigène B7-1 d’activation ; protéine B7 ; protéine B7 ; B7.1 ; B71 ; B7-1 ; protéine B7-1 ; antigène B7 d’activation des lymphocytes B ; Cd28l ; CD28LG ; CD28LG1 ; CD80 ; Cd80, un homologue chez le rat du ligand CD28/CTLA - 4 humain (B7-1) ; antigène CD80 ; antigène CD80 ; antigène CD80 (ligand 1 d’antigène CD28 1, antigène B7-1) ; molécule Cd80 ; précurseur protéique CD80 ; facteur costimulatoire CD80 ; variante de la molécule de costimulation IgV-CD80 ; contre-récepteur CTLA-4 B7.1 ; LAB7 ; Ly53 ; Ly-53 ; MIC17 ; sCD 80 ; SCD80 ; CD 80 soluble ; CD80 soluble ; molécule de co-stimulation des cellules T ; protéine de co-stimulation des cellules T B7-1 ; antigène d’activation des lymphocytes T CD80 ; TS/A-1 ; TSA1
Dose range
28 to 7.000 pg/ml
Sensitivity of the dosage
28 pg/ml
Conjugate
Biotin
Product type
ELISA
Brand
Invitrogen

Mouse CD80 quantitates mouse CD80 in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant mouse CD80.

Mouse CD80 quantitates mouse CD80 in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant mouse CD80.

CD80 (B7-1) and CD86 (B7-2) are critical CD28 costimulation molecule ligands of T cells and CTLA-4 inhibitor receptor (CD152). Both B7 molecules are expressed on professional antigen-presenting cells and are essential for T cell activation. These two molecules can also replace one another in this process. CD80 is rapidly induced on the surface of B cells activated in vitro, with B cell lines transformed by the Epstein Barr virus (EBV), with Burkitt lymphoma cell lines, with newly isolated follicular B lymphoma cells, T cells, and monocytes. The B7-1 B-Dactivation antigen provides regulatory signals for T-cell lymphocytes as a result of binding to CD28 and CTLA4 ligands in T cells. Diseases associated with CD80 protein dysfunction include epidermoid carcinoma of the gallbladder and myocarditis.

Sensitivity

Sensitivity of the dosage: 28 pg/ml.

Measurement range

Dose range: 28 to 7,000 pg/ml.

Duration of dosing

Total duration of dosing: 4 h 45 min.

Target

Target: CD80 (B7-1).

Samples

Type of sample: Plasma, Serum, Surnatant (Serum volume, 50 µl; plasma, 50 µl; supernatant, 50 µl).

Technical specifications

General
BrandInvitrogen
Supplier ref. (Fisher Scientific)17185609
Specifications
Accession numberAntigen B7-1 d-activation; protein B7; protein B7; B7.1; B71; B7-1; protein B7-1; antigen B7 of activation of B lymphocytes; Cd28l; CD28LG; CD28LG1 ; CD80; Cd80, a homologous rat CD28/CTLA - 4 human (B7-1) ; CD80 antigen ; CD80 antigen ; CD80 antigen (ligand 1 d)
Dose range28 to 7.000 pg/ml
Sensitivity of the dosage28 pg/ml
ConjugateBiotin
Product typeELISA
Type of samplePlasma, Serum, Surnatant
For use with (equipment)Colorimetric microplate reader
Genetic identification (Enter)Q00609
Gene symbol(s)CD80
Coefficient of inter-dose variation<12%
Coefficient of intra-dose variation<10%
Contents of kits96 pre-coated well plate, standard, dosing diluent concentrate, biotinylated detection antibody, SAV-HRP, washing pad, chromogen, stop solution, adhesive plate lids
Marker or dyeHRP
Quantity5 x 96 tests
Regulatory statusUse exclusively for research
TargetCD80 (B7-1)
Test time1 h 20 min
Physical characteristics
Volume of sampleSerum, 50 µl; plasma, 50 µl; supernatant, 50 µl
Storage and shipping
Storage conditions2°C to 8°C
Total duration of dosing4 h 45 min

Origin and customs

Manufacturer ref.EM16RBX5
Country of originUnited States
A question or a specific configuration?
Contact us for a quote.